Nattokinase Atherothrombotic Prevention Study
NCT02080520
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
265
Enrollment
OTHER
Sponsor class
Conditions
Prevention of Subclinical Atherosclerosis Progression
Prevention of Cognitive Decline
Interventions
DIETARY_SUPPLEMENT:
Nattokinase
OTHER:
Placebo
Sponsor
University of Southern California